NovoCure
NVCR
78 hedge funds and large institutions have $166M invested in NovoCure in 2016 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 7 closing their positions.
1,711% more call options, than puts
Call options by funds: $4.49M | Put options by funds: $248K
214% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 7
164% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 11
24.32% more ownership
Funds ownership: 0% → 24.32% (+24%)
24% more funds holding
Funds holding: 63 → 78 (+15)
3% more capital invested
Capital invested by funds: $161M → $166M (+$5.14M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$11.4M |
| 2 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$1.55M |
| 3 |
Morgan Stanley
New York
|
+$1.25M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$891K |
| 5 |
Goldman Sachs
New York
|
+$623K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.87M |
| 2 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$1.34M |
| 3 |
Millennium Management
New York
|
-$543K |
| 4 |
PCM
Prelude Capital Management
New York
|
-$337K |
| 5 |
CCM
Century Capital Management
Boston,
Massachusetts
|
-$251K |
NVCR Hedge Fund Activity: Q4 2016 in Review
78 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q4 2016, worth a combined $166M — up 3.2% from $161M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new NVCR positions and 7 closed out — a net gain of 15 holders — while 29 added to existing stakes and 11 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $11.4M. The largest seller was Deutsche Bank, cutting an estimated $1.87M.
- 78 institutional investors held NovoCure (NVCR) as of Q4 2016, up from 63 in Q3 2016.
- Funds reported $166M of NovoCure stock for Q4 2016, up 3.2% quarter-over-quarter.
- 22 funds opened new NovoCure positions in Q4 2016 and 7 closed out, a net change of +15 holders.
- The largest NovoCure buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $11.4M added.
- The largest NovoCure seller in Q4 2016 was Deutsche Bank, an estimated $1.87M sold.
Based on aggregated 13F filings for Q4 2016.